国产在线无码视频一区_免费看片A级毛片免费看_国产午夜福利精品一区二区三区_99久久人妻精品免费一区

您好, 歡迎來(lái)到化工儀器網(wǎng)

| 注冊(cè)| 產(chǎn)品展廳| 收藏該商鋪

13611715263

products

目錄:MedChemExpress LLC>>生化試劑>> Obinutuzumab | MCE

Obinutuzumab | MCE
  • Obinutuzumab | MCE
參考價(jià) 8100
具體成交價(jià)以合同協(xié)議為準(zhǔn)
參考價(jià) 8100
具體成交價(jià)以合同協(xié)議為準(zhǔn)
  • 品牌 MedChemExpress (MCE)
  • 型號(hào)
  • 廠商性質(zhì) 生產(chǎn)商
  • 所在地 國(guó)外
屬性

$NV_PropertyInfoName.SubString(0,25)

>

更新時(shí)間:2023-06-08 11:36:46瀏覽次數(shù):180評(píng)價(jià)

聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!

同類優(yōu)質(zhì)產(chǎn)品

更多產(chǎn)品
CAS 949142-50-1 純度 ≥99.4%
分子量 146298.97 供貨周期 現(xiàn)貨
規(guī)格 5 mg 貨號(hào) HY-P9910
應(yīng)用領(lǐng)域 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥/生物制藥
Obinutuzumab | MCEObinutuzumab (GA101) a novel glycoengineered Type II CD20 humanized IgG1 monoclonal antibody in development for non-Hodgkin lymphoma.

MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

Obinutuzumab

CAS No. : 949142-50-1

產(chǎn)品活性:Obinutuzumab (GA101) a novel glycoengineered Type II CD20 humanized IgG1 monoclonal antibody in development for non-Hodgkin lymphoma.

研究領(lǐng)域:Immunology/Inflammation

作用靶點(diǎn):CD20

In Vitro: Obinutuzumab is found to be superior to rituximab and ofatumumab in the induction of direct cell death (independent of mechanical manipulation required for cell aggregate disruption formed by antibody treatment), whereas it is 10 to 1,000 times less potent in mediating CDC. Obinutuzumab shows superior activity to rituximab and ofatumumab in ADCC and whole-blood B-cell depletion assays, and is comparable with these two in ADCP. Obinutuzumab also shows slower internalization rate upon binding to CD20 than rituximab and ofatumumab

In Vivo: Obinutuzumab is more active than rituximab administered at similar doses on established RL tumors. The antitumor effect of obinutuzumab against RL xenografts is dose dependent in terms of tumor growth inhibition (TGI). TGI is calculated using NCI formula at day 34 and shows values of 25, 75, and 85% for the 10, 30, and 100 mg/kg dosages of obinutuzumab, respectively. The higher doses of 30 and 100 mg/kg of obinutuzumab significantly inhibit the growth of RL tumors and result in some complete tumor remissions (10% and 30%, respectively). Tolerability of obinutuzumab with these regimens is excellent and no significant modification of body weight is observed. Obinutuzumab induces a strong antitumor effect, including complete tumor remission in the SU-DHL4 model and overall superior efficacy compared with both rituximab and ofatumumab. Obinutuzumab plus bendamustine achieves superior tumor growth inhibition versus rituximab plus bendamustine and shows a statistically significant effect versus the respective single treatments. Obinutuzumab plus chemotherapy is superior to the respective monotherapies.

相關(guān)產(chǎn)品:Plamotamab  |  Glofitamab  |  Divozilimab  |  Mosunetuzumab  |  Ofatumumab  |  Ublituximab  |  Ripertamab  |  Blontuvetmab  |  Imvotamab  |  Rituximab (anti-CD20)  |  Zuberitamab  |  Odronextamab  |  Tositumomab  |  Ocaratuzumab

熱門產(chǎn)品線:重組蛋白  |  化合物庫(kù)  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物  |  寡核苷酸  |  抗體  |  點(diǎn)擊化學(xué)

Trending products:Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫(kù),我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物;
•   50,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng);
•   產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目;
•   提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測(cè)分析,藥物篩選等專業(yè)技術(shù)服務(wù);
•   設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系;
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告,確保產(chǎn)品的高純度、高品質(zhì);
•   產(chǎn)品的生物活性多經(jīng)各國(guó)客戶實(shí)驗(yàn)驗(yàn)證;
•   Nature, Cell, Science 等多種頂級(jí)期刊及制藥 Patent 收錄了MCE客戶的科研成果;
•   專業(yè)團(tuán)隊(duì)跟蹤新的制藥及生命科學(xué)研究進(jìn)展,為您提供*新的活性化合物;
•   與世界各大制藥公司及*科研機(jī)構(gòu)建立了長(zhǎng)期的合作。

類藥多樣性化合物庫(kù)
顧客使用MCE產(chǎn)品發(fā)表的科研文獻(xiàn)
一站式藥篩新體驗(yàn)
MCE 您身邊的生物活性分子大師 | 抑制劑、激動(dòng)劑、化合物庫(kù)
重組蛋白 | 高純度、高穩(wěn)定性
磁珠

會(huì)員登錄

請(qǐng)輸入賬號(hào)

請(qǐng)輸入密碼

=

請(qǐng)輸驗(yàn)證碼

收藏該商鋪

標(biāo)簽:
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用:

提示

您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
在線留言

會(huì)員登錄

請(qǐng)輸入賬號(hào)

請(qǐng)輸入密碼

=

請(qǐng)輸驗(yàn)證碼

收藏該商鋪

該信息已收藏!
標(biāo)簽:
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用:
熱線電話 在線詢價(jià)
主站蜘蛛池模板: 天柱县| 手游| 威远县| 武城县| 株洲市| 泸定县| 嘉兴市| 永嘉县| 炉霍县| 灵宝市| 开封县| 竹北市| 平和县| 镇安县| 广汉市| 嘉祥县| 丁青县| 长武县| 梨树县| 广丰县| 抚州市| 孟州市| 盐城市| 株洲县| 梓潼县| 大方县| 特克斯县| 隆昌县| 汾西县| 深水埗区| 岳西县| 广安市| 鹤庆县| 阿坝县| 长岛县| 黄龙县| 海阳市| 闸北区| 榆社县| 呼伦贝尔市| 崇州市|